These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6792661)

  • 1. [Efficacy of rifampicin in the treatment of Meningococcus carriers].
    Borgoño JM; Rodríguez H; García J; Cánepa I
    Rev Chil Pediatr; 1981; 52(2):146-8. PubMed ID: 6792661
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningococcal meningitis following rifampin prophylaxis.
    Khuri-Bulos N
    Am J Dis Child; 1973 Nov; 126(5):689-91. PubMed ID: 4200808
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of rifampicin in healthy carriers of "N. meningitidis" (author's transl)].
    Delia S; Mauro A; Miceli MT
    Ann Sclavo; 1978; 20(5):675-80. PubMed ID: 111629
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of rifampin on the carrier state of Neisseria meningitidis and drug-sensitivity test (author's transl)].
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Nov; 15(6):371-2. PubMed ID: 6806022
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis.
    Schwartz B; Al-Tobaiqi A; Al-Ruwais A; Fontaine RE; A'ashi J; Hightower AW; Broome CV; Music SI
    Lancet; 1988 Jun; 1(8597):1239-42. PubMed ID: 2897515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of rifampin in treatment of meningococcal carriers.
    Deal WB; Sanders E
    N Engl J Med; 1969 Sep; 281(12):641-5. PubMed ID: 4980025
    [No Abstract]   [Full Text] [Related]  

  • 7. The carrier state: Neisseria meningitidis.
    Broome CV
    J Antimicrob Chemother; 1986 Jul; 18 Suppl A():25-34. PubMed ID: 3091563
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection of healthy carriers of Neisseria meningitidis among the school population of two towns of the province of Rome].
    Zucchetti P; Palmieri GC; Floccia M
    Ann Sclavo; 1973; 15(2):170-80. PubMed ID: 4204405
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of rifampicin on meningococcal carriage in family contacts in northern Nigeria.
    Blakebrough IS; Gilles HM
    J Infect; 1980 Jun; 2(2):137-43. PubMed ID: 6821084
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis for meningococcal disease.
    Artenstein MS
    JAMA; 1975 Mar; 231(10):1035-7. PubMed ID: 803581
    [No Abstract]   [Full Text] [Related]  

  • 11. [Meningococcus carriers].
    Corey G; Rodríguez H; Aguilar C; Greve E; Bustos R; Valenzuela ME
    Bol Oficina Sanit Panam; 1979 Sep; 87(3):238-46. PubMed ID: 159065
    [No Abstract]   [Full Text] [Related]  

  • 12. [Meningococcal project Telemark. Experiences after 5 years with contact tracing and eradication of the pathogenic bacteria in near contacts of the patients with meningococcal disease].
    Kristiansen BE; Tveten Y; Ask E; Knapskog AB; Reiten T; Steen-Johnsen J; Hopen G
    Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2933-7. PubMed ID: 8236200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alternating rifampicin and ceftriaxone for Neisseria meningitidis eradication in contacts].
    Shehab S; Leitner L; Bogokowsky B; Epstein I; Swartz TA
    Harefuah; 1991 Jun; 120(11):641-3. PubMed ID: 1937208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the sanative action of rifampicin on the meningococcal carrier state].
    Deviatkina NP; Demina AA; Orlova EV; Timina VP; Petrova IS
    Antibiotiki; 1978 Sep; 23(9):794-7. PubMed ID: 100048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aspects of the incidence of pharyngeal carriage of germs of the genus Neisseria in children aged 0-7 years, in a district of the city of Bucharest].
    Coman O; Dimache V; Bădescu M; Bădescu V; Brînzac V
    Pediatria (Bucur); 1971; 20(2):113-8. PubMed ID: 4996545
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of sulfadiazine in the prophylaxis of group A meningococcal carriers in Egypt.
    Hassan A; Girgis N; Sippel J; Sorensen K; Yassin M
    Trop Geogr Med; 1974 Mar; 26(1):87-90. PubMed ID: 4208558
    [No Abstract]   [Full Text] [Related]  

  • 17. [Occurence, prevention and therapy of meningococcic meningitis].
    Berger U
    Med Klin; 1975 Oct; 70(41):1628-35. PubMed ID: 810651
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure to prevent co-primary cases of meningococcal disease with rifampicin prophylaxis.
    Kaczmarski EB; Jones DM
    J Infect; 1992 Jan; 24(1):110-1. PubMed ID: 1548413
    [No Abstract]   [Full Text] [Related]  

  • 19. Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis.
    Simmons G; Jones N; Calder L
    J Antimicrob Chemother; 2000 Jun; 45(6):909-11. PubMed ID: 10837450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal meningitis in New Zealand with special reference to carrier rates in military trainees.
    Knights HT
    N Z Med J; 1972 Jul; 76(482):16-22. PubMed ID: 4628971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.